Sedentary Work Exerting up to 10 pounds (4.5 kg) of force occasionally and/or a negligible amount of force frequently or constantly to lift, carry, push, pull, or otherwise move objects, including the human body. Sedentary work involves sitting most of the time, but may involve walking or standing for brief periods of time. Jobs are sedentary if walking and standing are required only occasionally and other sedentary criteria are met.

Light Work Exerting up to 20 pounds (9.1 kg) of force occasionally and/or up to 10 pounds (4.5 kg) of force frequently, and/or negligible amount of force constantly to move objects. Physical demand requirements are in excess of those for Sedentary Work. Light Work usually requires walking or standing to a significant degree. However, if the use of the arm and/or leg controls requires exertion of forces greater than that for Sedentary Work and the worker sits most the time, the job is rated Light Work.

Medium Work Exerting up to 50 (22.7 kg) pounds of force occasionally, and/or up to 25 pounds (11.3 kg) of force frequently, and/or up to 10 pounds (4.5 kg) of forces constantly to move objects.

Heavy Work Exerting up to 100 pounds (45.4 kg) of force occasionally, and/or up to 50 pounds (22.7 kg) of force frequently, and/or in excess of 20 pounds (9.1 kg) of force constantly to move objects.

Very Heavy Work Exerting in excess of 100 pounds (45.4 kg) of force occasionally, and/or in excess of 50 pounds (22.7 kg) of force frequently, and/or in excess of 20 pounds (9.1 kg) of force constantly to move objects.

Job Classification

In most duration tables, five job classifications are displayed. These job classifications are based on the amount of physical effort required to perform the work. The classifications correspond to the Strength Factor classifications described in the United States Department of Labor's Dictionary of Occupational Titles. The following definitions are quoted directly from that publication.

Sedentary Work Exerting up to 10 pounds (4.5 kg) of force occasionally and/or a negligible amount of force frequently or constantly to lift, carry, push, pull, or otherwise move objects, including the human body. Sedentary work involves sitting most of the time, but may involve walking or standing for brief periods of time. Jobs are sedentary if walking and standing are required only occasionally and other sedentary criteria are met.

Light Work Exerting up to 20 pounds (9.1 kg) of force occasionally and/or up to 10 pounds (4.5 kg) of force frequently, and/or negligible amount of force constantly to move objects. Physical demand requirements are in excess of those for Sedentary Work. Light Work usually requires walking or standing to a significant degree. However, if the use of the arm and/or leg controls requires exertion of forces greater than that for Sedentary Work and the worker sits most the time, the job is rated Light Work.

Medium Work Exerting up to 50 (22.7 kg) pounds of force occasionally, and/or up to 25 pounds (11.3 kg) of force frequently, and/or up to 10 pounds (4.5 kg) of forces constantly to move objects.

Heavy Work Exerting up to 100 pounds (45.4 kg) of force occasionally, and/or up to 50 pounds (22.7 kg) of force frequently, and/or in excess of 20 pounds (9.1 kg) of force constantly to move objects.

Very Heavy Work Exerting in excess of 100 pounds (45.4 kg) of force occasionally, and/or in excess of 50 pounds (22.7 kg) of force frequently, and/or in excess of 20 pounds (9.1 kg) of force constantly to move objects.

Cancer


Related Terms

  • Carcinoma
  • Malignant Neoplasm
  • Tumor

Medical Codes

ICD-9-CM:
140.0 - Malignant Neoplasm of Lip; Upper Lip, Vermilion Border; Upper Lip: NOS, External, Lipstick Area
140.1 - Malignant Neoplasm of Lip; Lower Lip, Vermilion Border; Lower Lip: NOS, External; Lipstick Area
140.3 - Malignant Neoplasm of Lip; Upper Lip, Inner Aspect; Upper Lip: Buccal Aspect, Frenulum; Mucosa, Oral Aspect
140.4 - Malignant Neoplasm of Lip; Lower Lip, Inner Aspect; Buccal Aspect; Frenulum; Mucosa; Oral Aspect
140.5 - Malignant Neoplasm of Lip; Lip, Unspecified, Inner aspect; Buccal aspect; Frenulum; Mucosa; Oral Aspect
140.6 - Malignant Neoplasm of Lip; Commissure of Lip; Labial Commissure
140.8 - Malignant Neoplasm of Lip; Other Sites of Lip; Malignant Neoplasm of Contiguous or Overlapping Sites of Lip Whose Point of Origin Cannot be Determined
140.9 - Malignant Neoplasm of Lip; Lip, Unspecified, Vermilion Border; External; Lipstick Area
147.0 - Malignant Neoplasm, Superior Wall; Roof of Nasopharynx
147.1 - Malignant Neoplasm, Posterior Wall; Adenoid; Pharyngeal Tonsil
147.2 - Malignant Neoplasm, Lateral Wall; Fossa of Rosenmüller; Opening of Auditory Tube; Pharyngeal Recess
147.3 - Malignant Neoplasm, Anterior Wall; Floor of Nasopharynx; Nasopharyngeal [Posterior] [Superior] Surface of Soft palate; Posterior Margin of Nasal Septum and Choanae
147.8 - Malignant Neoplasm, Other Specified Sites of Nasopharynx; Malignant Neoplasm of Contiguous or Overlapping Sites of Nasopharynx Whose Point of Origin Cannot be Determined
147.9 - Malignant Neoplasm, Nasopharynx, Unspecified
148.0 - Malignant Neoplasm, Postcricoid Region
148.1 - Malignant Neoplasm, Pyriform Sinus; Pyriform Fossa
148.2 - Malignant Neoplasm, Aryepiglottic Fold, Hypopharyngeal Aspect; Aryepiglottic Fold or Interarytenoid Fold: NOS, Marginal Zone
148.3 - Malignant Neoplasm, Posterior Hypopharyngeal Wall
148.8 - Malignant Neoplasm, Other Specified Sites of Hypopharynx; Malignant Neoplasm of Contiguous or Overlapping Sites of Hypopharynx Whose Point of Origin Cannot Be Determined
148.9 - Malignant Neoplasm, Hypopharynx, Unspecified
149.0 - Malignant Neoplasm, Pharynx, Unspecified
149.1 - Malignant Neoplasm, Waldeyers Ring
149.8 - Malignant Neoplasm, Other
149.9 - Malignant Neoplasm, Ill-defined
189.0 - Malignant Neoplasm of Kidney and Other and Unspecified Urinary Organs; Kidney, except Pelvis; Kidney NOS; Kidney Parenchyma
189.1 - Malignant Neoplasm of Kidney and Other and Unspecified Urinary Organs; Renal Pelvis; Renal Calyces; Ureteropelvic Junction
189.2 - Malignant Neoplasm of Kidney and Other and Unspecified Urinary Organs; Ureter
189.3 - Malignant Neoplasm of Kidney and Other and Unspecified Urinary Organs; Urethra
189.4 - Malignant Neoplasm of Kidney and Other and Unspecified Urinary Organs; Paraurethral Glands
189.8 - Malignant Neoplasm of Kidney and Other and Unspecified Urinary Organs; Other Specified Sites of Urinary Organs
189.9 - Malignant Neoplasm of Kidney and Other and Unspecified Urinary Organs Urinary Organ, Site Unspecified; Urinary System NOS
194.0 - Malignant Neoplasm of Other Endocrine Glands and Related Structures, Adrenal Gland; Adrenal Cortex; Adrenal Medulla; Suprarenal Gland
194.1 - Malignant Neoplasm of other Endocrine Glands and Related Structures, Parathyroid Gland
194.3 - Malignant Neoplasm of Other Endocrine Glands and Related Structures, Pituitary Gland and Craniopharyngeal Duct; Craniobuccal Pouch; Hypophysis; Rathkes Pouch; Sella Turcica
194.4 - Malignant Neoplasm of other Endocrine Glands and Related Structures, Pineal Gland, Malignant
194.5 - Malignant Neoplasm of other Endocrine Glands and Related Structures, Carotid Body
194.6 - Malignant Neoplasm of other Endocrine Glands and Related Structures, Aortic Body and Other Paraganglia; Coccygeal Body; Glomus Jugulare; Para-aortic Body
194.8 - Malignant Neoplasm of other Endocrine Glands and Related Structures, Other
194.9 - Malignant Neoplasm of Other Endocrine Glands and Related Structures, Endocrine Gland, Site Unspecified
195.0 - Malignant Neoplasm of Other and Ill-defined Sites, Head, Face, and Neck; Cheek NOS, Jaw NOS, Nose NOS, Supraclavicular Region NOS
195.1 - Malignant Neoplasm of Other and Ill-defined Sites, Thorax; Axilla; Chest (Wall) NOS; Intrathoracic Nos
195.2 - Malignant Neoplasm of Other and Ill-defined Sites, Abdomen; Intra-abdominal NOS
195.3 - Malignant Neoplasm of Other and Ill-defined Sites, Pelvis; Groin; Presacral Region; Sacrococcygeal Region; Rectovaginal (Septum); Rectovesical (Septum)
195.4 - Malignant Neoplasm of Other and Ill-defined Sites, Upper Limb
195.5 - Malignant Neoplasm of Other and Ill-defined Sites, Lower Limb
195.8 - Malignant Neoplasm of Other and Ill-defined sites, Other Specified Sites
197.0 - Secondary Malignant Neoplasm of Respiratory and Digestive Systems; Lung, Bronchus
197.1 - Secondary Malignant Neoplasm of Respiratory and Digestive Systems; Mediastinum
197.2 - Secondary Malignant Neoplasm of Respiratory and Digestive Systems; Pleura
197.3 - Secondary Malignant Neoplasm of Respiratory and Digestive Systems; Other Respiratory Organs; Trachea
197.4 - Secondary Malignant Neoplasm of Respiratory and Digestive Systems; Small Intestine, Including Duodenum
197.5 - Secondary Malignant Neoplasm of Respiratory and Digestive Systems; Large Intestine and Rectum
197.6 - Secondary Malignant Neoplasm of Respiratory and Digestive Systems; Retroperitoneum and Peritoneum
197.7 - Secondary Malignant Neoplasm of Respiratory and Digestive Systems; Liver, Specified as Secondary
199.0 - Malignant Neoplasm without Specification of Site; Disseminated; Carcinomatosis Unspecified Site (Primary) (Secondary); Cancer Unspecified Site (Primary) (Secondary); Malignancy Unspecified Site (Primary) (Secondary); Multiple Cancer Unspecified Site (Primary) (Secondary)
199.1 - Malignant Neoplasm without Specification of Site; Other; Cancer Unspecified Site (Primary) (Secondary); Carcinoma Unspecified Site (Primary) (Secondary); Malignancy Unspecified Site (Primary) (Secondary)
199.2 - Malignant neoplasm associated with transplant organ
200.00 - Reticulosarcoma; Nodular; Pleomorphic Cell Type; Reticulum Cell Type; Pleomorphic Cell Type; Unspecified Site, Extranodal and Solid Organ Sites
200.01 - Reticulosarcoma; Nodular; Pleomorphic Cell Type; Reticulum Cell Type; Pleomorphic Cell Type; Lymph Nodes of Head, Face, and Neck
200.02 - Reticulosarcoma; Nodular; Pleomorphic Cell Type; Reticulum Cell Type; Pleomorphic Cell Type; Intrathoracic Lymph Nodes
200.03 - Reticulosarcoma; Nodular; Pleomorphic Cell Type; Reticulum Cell Type; Pleomorphic Cell Type; Intra-abdominal Lymph Nodes
200.04 - Reticulosarcoma; Nodular; Pleomorphic Cell Type; Reticulum Cell Type; Pleomorphic Cell Type; Lymph Nodes of Axilla and Upper Limb
200.05 - Reticulosarcoma; Nodular; Pleomorphic Cell Type; Reticulum Cell Type; Pleomorphic Cell Type; Lymph Nodes of Inguinal Region and Lower Limb
200.06 - Reticulosarcoma; Nodular; Pleomorphic Cell Type; Reticulum Cell Type; Pleomorphic Cell Type; Intrapelvic Lymph Nodes
200.07 - Reticulosarcoma; Nodular; Pleomorphic Cell Type; Reticulum Cell Type; Pleomorphic Cell Type; Spleen
200.08 - Reticulosarcoma; Nodular; Pleomorphic Cell Type; Reticulum Cell Type; Pleomorphic Cell Type; Lymph Nodes of Multiple Sites
200.10 - Lymphosarcoma; Lymphoblastoma (Diffuse); Lymphoma (Malignant); Lymphosarcoma NOS; Unspecified Site, Extranodal and Solid Organ Sites
200.11 - Lymphosarcoma; Lymphoblastoma (Diffuse); Lymphoma (Malignant); Lymphosarcoma NOS; Lymph Nodes of Head, Face, and Neck
200.12 - Lymphosarcoma; Lymphoblastoma (Diffuse); Lymphoma (Malignant); Lymphosarcoma NOS; Intrathoracic Lymph Nodes
200.13 - Lymphosarcoma; Lymphoblastoma (Diffuse); Lymphoma (Malignant); Lymphosarcoma NOS; Intra-Abdominal Lymph Nodes
200.14 - Lymphosarcoma; Lymphoblastoma (Diffuse); Lymphoma (Malignant); Lymphosarcoma NOS; Lymph Nodes of Axilla and Upper Limb
200.15 - Lymphosarcoma; Lymphoblastoma (Diffuse); Lymphoma (Malignant); Lymphosarcoma NOS; Lymph Nodes of Inguinal Region and Lower Limb
200.16 - Lymphosarcoma; Lymphoblastoma (Diffuse); Lymphoma (Malignant); Lymphosarcoma NOS; Intrapelvic Lymph Nodes
200.17 - Lymphosarcoma; Lymphoblastoma (Diffuse); Lymphoma (Malignant); Lymphosarcoma NOS; Spleen
200.18 - Lymphosarcoma; Lymphoblastoma (Diffuse); Lymphoma (Malignant); Lymphosarcoma NOS; Lymph Nodes of Multiple Sites
200.20 - Burkitts Tumor or Lymphoma; Malignant Lymphoma Burkitts Type; Unspecified Site, Extranodal and Solid Organ Sites
200.21 - Burkitts Tumor or Lymphoma; Malignant Lymphoma Burkitts Type; Lymph Nodes of Head, Face, and Neck
200.22 - Burkitts Tumor or Lymphoma; Malignant Lymphoma Burkitts Type; Intrathoracic Lymph Nodes
200.23 - Burkitts Tumor or Lymphoma; Malignant Lymphoma Burkitts Type; Intra-Abdominal Lymph Nodes
200.24 - Burkitts Tumor or Lymphoma; Malignant Lymphoma Burkitts Type; Lymph Nodes of Axilla and Upper Limb
200.25 - Burkitts Tumor or Lymphoma; Malignant Lymphoma Burkitts Type; Lymph Nodes of Inguinal Region and Lower Limb
200.26 - Burkitts Tumor or Lymphoma; Malignant Lymphoma Burkitts Type; Intrapelvic Lymph Nodes
200.27 - Burkitts Tumor or Lymphoma; Malignant Lymphoma Burkitts Type; Spleen
200.28 - Burkitts Tumor or Lymphoma; Malignant Lymphoma Burkitts Type; Lymph Nodes of Multiple Sites
200.30 - Marginal Zone Lymphoma; Extranodal Marginal Zone B Cell Lymphoma, Mucosa Associated Lymphoid Tissue, Nodal Marginal Zone B Cell Lymphoma, Splenic Marginal Zone B Cell Lymphoma; Unspecified Site, Extranodal and Solid Organ Sites
200.31 - Marginal Zone Lymphoma; Extranodal Marginal Zone B Cell Lymphoma, Mucosa Associated Lymphoid Tissue, Nodal Marginal Zone B Cell Lymphoma, Splenic Marginal Zone B Cell Lymphoma; Lymph Nodes of Head, Face, and Neck
200.32 - Marginal Zone Lymphoma; Extranodal Marginal Zone B Cell Lymphoma, Mucosa Associated Lymphoid Tissue, Nodal Marginal Zone B Cell Lymphoma, Splenic Marginal Zone B Cell Lymphoma; Intrathoracic Lymph Nodes
200.33 - Marginal Zone Lymphoma; Extranodal Marginal Zone B Cell Lymphoma, Mucosa Associated Lymphoid Tissue, Nodal Marginal Zone B Cell Lymphoma, Splenic Marginal Zone B Cell Lymphoma; Intra-Abdominal Lymph Nodes
200.34 - Marginal Zone Lymphoma; Extranodal Marginal Zone B Cell Lymphoma, Mucosa Associated Lymphoid Tissue, Nodal Marginal Zone B Cell Lymphoma, Splenic Marginal Zone B Cell Lymphoma; Lymph Nodes of Axilla and Upper Limb
200.35 - Marginal Zone Lymphoma; Extranodal Marginal Zone B Cell Lymphoma, Mucosa Associated Lymphoid Tissue, Nodal Marginal Zone B Cell Lymphoma, Splenic Marginal Zone B Cell Lymphoma; Lymph Nodes of Inguinal Region and Lower Limb
200.36 - Marginal Zone Lymphoma; Extranodal Marginal Zone B Cell Lymphoma, Mucosa Associated Lymphoid Tissue, Nodal Marginal Zone B Cell Lymphoma, Splenic Marginal Zone B Cell Lymphoma; Intrapelvic Lymph Nodes
200.37 - Marginal Zone Lymphoma; Extranodal Marginal Zone B Cell Lymphoma, Mucosa Associated Lymphoid Tissue, Nodal Marginal Zone B Cell Lymphoma, Splenic Marginal Zone B Cell Lymphoma; Spleen
200.38 - Marginal Zone Lymphoma; Extranodal Marginal Zone B Cell Lymphoma, Mucosa Associated Lymphoid Tissue, Nodal Marginal Zone B Cell Lymphoma, Splenic Marginal Zone B Cell Lymphoma; Lymph Nodes of Multiple Sites
200.40 - Mantle Cell Lymphoma; Unspecified Site, Extranodal and Solid Organ Sites
200.41 - Mantle Cell Lymphoma; Lymph Nodes of Head, Face, and Neck
200.42 - Mantle Cell Lymphoma; Intrathoracic Lymph Nodes
200.43 - Mantle Cell Lymphoma; Intra-abdominal Lymph Nodes
200.44 - Mantle Cell Lymphoma; Lymph Nodes of Axilla and Upper Limb
200.45 - Mantle Cell Lymphoma; Lymph Nodes of Inguinal Region and Lower Limb
200.46 - Mantle Cell Lymphoma; Intrapelvic Lymph Nodes
200.47 - Mantle Cell Lymphoma; Spleen
200.48 - Mantle Cell Lymphoma; Lymph Nodes of Multiple Sites
200.50 - Primary Central Nervous System Lymphoma; Unspecified Site, Extranodal and Solid Organ Sites
200.51 - Primary Central Nervous System Lymphoma; Lymph Nodes of Head, Face, and Neck
200.52 - Primary Central Nervous System Lymphoma; Intrathoracic Lymph Nodes
200.53 - Primary Central Nervous System Lymphoma; Intra-abdominal Lymph Nodes
200.54 - Primary Central Nervous System Lymphoma; Lymph Nodes of Axilla and Upper Limb
200.55 - Primary Central Nervous System Lymphoma; Lymph Nodes of Inguinal Region and Lower Limb
200.56 - Primary Central Nervous System Lymphoma; Intrapelvic Lymph Nodes
200.57 - Primary Central Nervous System Lymphoma; Spleen
200.58 - Primary Central Nervous System Lymphoma; Lymph Nodes of Multiple Sites
200.60 - Anaplastic Large Cell Lymphoma; Unspecified Site, Extranodal and Solid Organ Sites
200.61 - Anaplastic Large Cell Lymphoma; Lymph Nodes of Head, Face, and Neck
200.62 - Anaplastic Large Cell Lymphoma; Intrathoracic Lymph Nodes
200.63 - Anaplastic Large Cell Lymphoma; Intra-abdominal Lymph Nodes
200.64 - Anaplastic Large Cell Lymphoma; Lymph Nodes of Axilla and Upper Limb
200.65 - Anaplastic Large Cell Lymphoma; Lymph Nodes of Inguinal Region and Lower Limb
200.66 - Anaplastic Large Cell Lymphoma; Intrapelvic Lymph Nodes
200.67 - Anaplastic Large Cell Lymphoma; Spleen
200.68 - Anaplastic Large Cell Lymphoma; Lymph Nodes of Multiple Sites
200.70 - Large Cell Lymphoma; Unspecified Site, Extranodal and Solid Organ Sites
200.71 - Large Cell Lymphoma; Lymph Nodes of Head, Face, and Neck
200.72 - Large Cell Lymphoma; Intrathoracic Lymph Nodes
200.73 - Large Cell Lymphoma; Intra-Abdominal Lymph Nodes
200.74 - Large Cell Lymphoma; Lymph Nodes of Axilla and Upper Limb
200.75 - Large Cell Lymphoma; Lymph Nodes of Inguinal Region and Lower Limb
200.76 - Large Cell Lymphoma; Intrapelvic Lymph Nodes
200.77 - Large Cell Lymphoma; Spleen
200.78 - Large Cell Lymphoma; Lymph Nodes of Multiple Sites
200.80 - Lymphoma, Other Named Variants; Lymphoma (Malignant): Lymphoplasmacytoid Type, Mixed Lymphocytic-histiocytic (Diffuse); Lymphosarcoma, Mixed Cell Type (Diffuse); Reticulolymphosarcoma (Diffuse); Unspecified Site, Extranodal and Solid Organ Sites
200.81 - Lymphoma, Other Named Variants; Lymphoma (Malignant): Lymphoplasmacytoid Type, Mixed Lymphocytic-histiocytic (Diffuse); Lymphosarcoma, Mixed Cell Type (Diffuse); Reticulolymphosarcoma (Diffuse); Lymph Nodes of Head, Face, and Neck
200.82 - Lymphoma, Other Named Variants; Lymphoma (Malignant): Lymphoplasmacytoid Type, Mixed Lymphocytic-histiocytic (Diffuse); Lymphosarcoma, Mixed Cell Type (Diffuse); Reticulolymphosarcoma (Diffuse); Intrathoracic Lymph Nodes
200.83 - Lymphoma, Other Named Variants; Lymphoma (Malignant): Lymphoplasmacytoid Type, Mixed Lymphocytic-histiocytic (Diffuse); Lymphosarcoma, Mixed Cell Type (Diffuse); Reticulolymphosarcoma (Diffuse); Intra-Abdominal Lymph Nodes
200.84 - Lymphoma, Other Named Variants; Lymphoma (Malignant): Lymphoplasmacytoid Type, Mixed Lymphocytic-histiocytic (Diffuse); Lymphosarcoma, Mixed Cell Type (Diffuse); Reticulolymphosarcoma (Diffuse); Lymph Nodes of Axilla and Upper Limb
200.85 - Lymphoma, Other Named Variants; Lymphoma (Malignant): Lymphoplasmacytoid Type, Mixed Lymphocytic-histiocytic (Diffuse); Lymphosarcoma, Mixed Cell Type (Diffuse); Reticulolymphosarcoma (Diffuse); Lymph Nodes of Inguinal Region and Lower Limb
200.86 - Lymphoma, Other Named Variants; Lymphoma (Malignant): Lymphoplasmacytoid Type, Mixed Lymphocytic-histiocytic (Diffuse); Lymphosarcoma, Mixed Cell Type (Diffuse); Reticulolymphosarcoma (Diffuse); Intrapelvic Lymph Nodes
200.87 - Lymphoma, Other Named Variants; Lymphoma (Malignant): Lymphoplasmacytoid Type, Mixed Lymphocytic-histiocytic (Diffuse); Lymphosarcoma, Mixed Cell Type (Diffuse); Reticulolymphosarcoma (Diffuse); Spleen
200.88 - Lymphoma, Other Named Variants; Lymphoma (Malignant): Lymphoplasmacytoid Type, Mixed Lymphocytic-histiocytic (Diffuse); Lymphosarcoma, Mixed Cell Type (Diffuse); Reticulolymphosarcoma (Diffuse); Lymph Nodes of Multiple Sites
202.00 - Nodular Lymphoma; Brill-Symmers Disease; Follicular (Giant); Lymphocytic, Nodular; Follicular (Giant); Nodular; Reticulosarcoma, Follicular or Nodular; Unspecified Site, Extranodal and Solid Organ Sites
202.01 - Nodular Lymphoma; Brill-Symmers Disease; Follicular (Giant); Lymphocytic, Nodular; Follicular (Giant); Nodular; Reticulosarcoma, Follicular or Nodular; Lymph Nodes of Head, Face, and Neck
202.02 - Nodular Lymphoma; Brill-Symmers Disease; Follicular (Giant); Lymphocytic, Nodular; Follicular (Giant); Nodular; Reticulosarcoma, Follicular or Nodular; Intrathoracic Lymph Nodes
202.03 - Nodular Lymphoma; Brill-Symmers Disease; Follicular (Giant); Lymphocytic, Nodular; Follicular (Giant); Nodular; Reticulosarcoma, Follicular or Nodular; Intra-Abdominal Lymph Nodes
202.04 - Nodular Lymphoma; Brill-Symmers Disease; Follicular (Giant); Lymphocytic, Nodular; Follicular (Giant); Nodular; Reticulosarcoma, Follicular or Nodular; Lymph Nodes of Axilla and Upper Limb
202.05 - Nodular Lymphoma; Brill-Symmers Disease; Follicular (Giant); Lymphocytic, Nodular; Follicular (Giant); Nodular; Reticulosarcoma, Follicular or Nodular; Lymph Nodes of Inguinal Region and Lower Limb
202.06 - Nodular Lymphoma; Brill-Symmers Disease; Follicular (Giant); Lymphocytic, Nodular; Follicular (Giant); Nodular; Reticulosarcoma, Follicular or Nodular; Intrapelvic Lymph Nodes
202.07 - Nodular Lymphoma; Brill-Symmers Disease; Follicular (Giant); Lymphocytic, Nodular; Follicular (Giant); Nodular; Reticulosarcoma, Follicular or Nodular; Spleen
202.08 - Nodular Lymphoma; Brill-Symmers Disease; Follicular (Giant); Lymphocytic, Nodular; Follicular (Giant); Nodular; Reticulosarcoma, Follicular or Nodular; Lymph Nodes of Multiple Sites
230.9 - Carcinoma in Situ of Other and Unspecified Digestive Organs; Digestive Organ NOS; Gastrointestinal Tract NOS; Pancreas; Spleen
231.0 - Larynx; Arytenoid; Cricoid; Cuneiform; Thyroid; Posterior Surface; Suprahyoid Portion; Vocal Cords (False) (True)
231.1 - Carcinoma in Situ of Respiratory System, Trachea
231.2 - Carcinoma in Situ of Bronchus and Lung; Carina, Hilus of Lung
231.8 - Other Specified Parts of Respiratory System; Accessory Sinuses; Middle Ear; Nasal Cavities; Pleura
231.9 - Respiratory System, Part Unspecified
233.0 - Carcinoma in Situ of the Breast
233.2 - Carcinoma in Situ of Other and Unspecified Parts of Uterus
233.30 - Carcinoma in Situ; Other and Unspecified Female Genital Organs; Unspecified Female Genital Organ
233.31 - Carcinoma in Situ; Other and Unspecified Female Genital Organs; Vagina; Severe Dysplasia of Vagina, Vaginal Intraepithelial Neoplasia [VAIN III]
233.32 - Carcinoma in Situ; Other and Unspecified Female Genital Organs; Vulva; Severe Dysplasia of Vulva, Vulvar Intraepithelial Neoplasia [VIN III]
233.39 - Carcinoma in Situ; Other and Unspecified Female Genital Organs; Other Female Genital Organ
233.4 - Carcinoma in Situ of Prostate
233.5 - Carcinoma in Situ of Breast and Genitourinary System, Penis
233.6 - Carcinoma in Situ of Other and Unspecified Male Genital Organs
233.7 - Carcinoma in Situ of Bladder
233.9 - Carcinoma in Situ of Other and Unspecified Urinary Organs
234.0 - Carcinoma in Situ of Other and Unspecified Sites, Eye
234.9 - Carcinoma in Situ of Other and Unspecified Sites, Site unspecified; Carcinoma in Situ NOS
236.0 - Neoplasm of Uncertain Behavior of Genitourinary Organs, Uterus
236.2 - Neoplasm of Uncertain Behavior of Genitourinary Organs, Ovary
236.3 - Neoplasm of Uncertain Behavior of Genitourinary Organs, Other and Unspecified Female Genital Organs
236.4 - Neoplasm of Uncertain Behavior of Genitourinary Organs, Testis
236.5 - Neoplasm of Uncertain Behavior of Genitourinary Organs, Prostate
236.6 - Neoplasm of Uncertain Behavior of Genitourinary Organs; Other and unspecified male genital organs
236.7 - Neoplasm of Uncertain Behavior of Genitourinary Organs; Bladder Polyps
236.90 - Neoplasms of Uncertain Behavior or Genitourinary Organs, Urinary Organ, Unspecified
236.91 - Neoplasm of Uncertain Behavior of Genitourinary Organs; Kidney and Ureter
236.99 - Neoplasm of Uncertain Behavior of Genitourinary Organs, Other and Unspecified Urinary Organs, Other
237.0 - Neoplasm of Uncertain Behavior of Endocrine Glands and Nervous System; Pituitary Gland and Craniopharyngeal Duct
237.1 - Neoplasm of Uncertain Behavior of Endocrine Glands and Nervous System, Pineal Gland Neoplasm
237.2 - Neoplasm of Uncertain Behavior of Endocrine Glands and Nervous System; Adrenal Gland; Suprarenal Gland
237.3 - Neoplasm of Uncertain Behavior of Endocrine Glands and Nervous System; Paraganglia; Aortic body; Carotid body; Coccygeal Body; Glomus Jugulare
237.4 - Other and Unspecified Endocrine Glands; Parathyroid Gland; Thyroid Gland
237.6 - Neoplasm of Uncertain Behavior of Endocrine Glands and Nervous System, Meninges, NOS, Cerebral, Spinal
237.70 - Neurofibromatosis, Unspecified
237.71 - Neurofibromatosis, Type I; von Recklinghausens Disease
237.72 - Neurofibromatosis, Type II; Acoustic Neurofibromatosis
237.73 - Schwannomatosis
237.79 - Other Neurofibromatosis
237.9 - Other and Unspecified Parts of Nervous System; Cranial Nerves
238.0 - Neoplasm of Uncertain Behavior of Bone and Articular Cartilage
238.1 - Neoplasm of Uncertain Behavior of Other and Unspecified Sites and Tissues; Connective and Other Soft Tissue; Peripheral, Sympathetic, and Parasympathetic Nerves and Ganglia
238.3 - Neoplasm of Uncertain Behavior of Other and Unspecified Sites and Tissues, Breast
238.4 - Neoplasm of Uncertain Behavior, Polycythemia Vera
238.5 - Neoplasm of Uncertain Behavior of Other and Unspecified Sites and Tissues; Histiocytic and Mast Cells; Mast Cell Tumor NOS; Mastocytoma NOS
238.6 - Neoplasm of Uncertain Behavior of Other and Unspecified Sites and Tissues; Plasma Cells; Plasmacytoma NOS; Solitary Myeloma
238.71 - Essential Thrombocythemia
238.72 - Low Grade Myelodysplastic Syndrome Lesions; Refractory anemia with excess blasts-1(RAEB-1)
238.73 - High Grade Myelodysplastic Syndrome Lesions
238.74 - Myelodysplastic Syndrome with 5q Deletion
238.75 - Myelodysplastic Syndrome, Unspecified
238.76 - Myelofibrosis with Myeloid Metaplasia
238.77 - Post-transplant lymphoproliferative disorder (PTLD)
238.79 - Other Lymphatic and Hematopoietic Tissues
238.8 - Neoplasm of Uncertain Behavior of Other and Unspecified Sites and Tissues; Other specified sites; Eye; Heart
238.9 - Neoplasm of Uncertain Behavior of Other and Unspecified Sites and Tissues; Site unspecified
239.1 - Neoplasm of Unspecified Nature of Respiratory System
239.2 - Neoplasms of Unspecified Nature of Bone, Soft Tissue, and Skin
239.3 - Neoplasm of Unspecified Nature; Breast
239.7 - Neoplasm of Unspecified Nature, Endocrine Glands and Other Parts of Nervous System

Overview

Cancer is a general term used to identify tissue that grows abnormally fast and that loses any specialized characteristics of the tissue from which it has arisen. Cancer tumors (malignant neoplasms) tend to grow in an unrestricted fashion and expand into surrounding tissues and organs. Cells from a malignant neoplasm can separate from the initial tumor, travel to a different site (usually via the bloodstream or lymphatic system), and then start dividing and replicating themselves to form a new, secondary tumor (metastasis).

Cancer usually develops in major organs such as the lungs, breasts, intestines, pancreas, lymphatic system (Hodgkin's and non-Hodgkin's lymphomas), the prostate gland in men, and the ovaries in women. Other sites of cancer formation include the urinary bladder, skin, mouth, lips, throat, kidney, thyroid, esophagus, brain, adrenal gland, stomach, and in women, the uterus. Malignant neoplasms can also develop in the blood cell-forming tissues located in the bone marrow (leukemias).

It is not completely clear what causes cells to become cancerous and begin growing in an uncontrolled fashion. One possible mechanism is that cancer-causing agents (carcinogens) may act on certain genes (oncogenes) within cells to trigger gene mutations. The change in oncogenes is then passed on to all offspring cells, which divide more rapidly than the normal surrounding cells. Usually, the offspring cells show abnormal physical characteristics, including lack of differentiation, so they no longer perform the specialized task that they were meant to do. Because cancer cells escape the controls that keep healthy cells from growing abnormally, a malignant tumor can form. It may take years before the tumor becomes large enough to cause symptoms, so by the time of discovery, the cancer may have spread (metastasized) to other vital organs such as the liver, lungs, bones, or brain.

Treatment of cancer is guided by staging the disease through the examination of cells from affected tissue, the surrounding area, and areas of possible metastasis. Staging helps to determine the tumor size, location and if the cancer has invaded lymph nodes and other organs. Stages are expressed numerically as I, II, III, or IV, and described as "localized," "regional," and "distant." Staging not only helps determine treatment, but it also affects prognosis. Generally, the lower the numerical stage, the more likely that treatment will have a good outcome. A more localized cancer may be treated with surgery, but a cancer that has metastasized is difficult to surgically remove. For more specific information on treatment see entries for cancer of the bladder, lung, ovary, thyroid, kidney, brain, prostate, breast, bone, cervix, colon, esophagus, liver, oropharynx, oral cavity, pancreas, pleura, rectum, skin, small intestine, stomach, testicle, Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma and hepatic angiosarcoma.

Incidence and Prevalence: Cancer incidence is estimated to be 468.1 new cancers diagnosed per 100,000 Americans annually, including prostate cancer 155.4 per 100,000; breast cancer 125.5 per 100,000; colon cancer 47.4 per 100,000; and lung cancer 62.9 per 100,000 (SEER). Types of cancer with rising incidence include female lung cancer, non-Hodgkin lymphoma, and skin cancer (melanoma) (“Cancer Trends Report”). Cancer is second only to heart disease as the leading cause of death in the US.

Source: Medical Disability Advisor



Causation and Known Risk Factors

Risk factors for cancer include, among others, cigarette smoking or the use of smokeless tobacco; a diet that is high in fat or calories, or low in fiber or calcium; high alcohol consumption; low physical activity; obesity; infection with certain viruses (e.g., hepatitis B and C, Epstein-Barr virus, human immunodeficiency virus [HIV]) or other biological agents (e.g., Schistosoma, Helicobacter pylori); radiation exposure (either environmental or high-dose therapeutic); anti-cancer (cytotoxic) drugs treatment; occupational or environmental carcinogen exposure, such as to asbestos, heavy metals, pesticides, hair dressing compounds, soot, tar, formaldehyde, vinyl chloride, and wood dusts; and advanced age. In women, risk factors include certain reproductive and sexual factors such as early age at first menstruation (menarche), late age at menopause, never having been pregnant (nulliparity), not carrying a pregnancy beyond 6 months, late first pregnancy (35 years or older), and having multiple sexual partners, as well as infection with certain viruses (e.g., human papillomavirus), hormone therapy (e.g., estrogen, androgenic steroids), and low socioeconomic status. Gender may predispose some individuals to certain types of cancer. A genetic predisposition for certain cancers may occur within family groups. Blacks are at highest risk for new cancers; cancer risk is low in Native Americans and Alaska Natives (“Cancer Trends Report”).

Source: Medical Disability Advisor



References

Cited

"Cancer Trends Report." National Cancer Institute. Dec. 2007. New Media Systems, LLC. 17 Aug. 2009 <http://progressreport.cancer.gov>.

"SEER (Surveillance, Epidemiology, and End-Results)." National Cancer Institute. Dec. 2007. New Media Systems, LLC. 17 Aug. 2009 <http://www.cancer.gov>.

General

American Cancer Society. 19 May 2005 <http://www.cancer.org/docroot/home/index.asp>.

Source: Medical Disability Advisor






Feedback
Send us comments, suggestions, corrections, or anything you would like us to hear. If you are not logged in, you must include your email address, in order for us to respond. We cannot, unfortunately, respond to every comment. If you are seeking medical advice, please contact your physician. Thank you!
Send this comment to:
Sales Customer Support Content Development
 
This publication is designed to provide accurate and authoritative information in regard to the subject matter covered. It is published with the understanding that the author, editors, and publisher are not engaged in rendering medical, legal, accounting or other professional service. If medical, legal, or other expert assistance is required, the service of a competent professional should be sought. We are unable to respond to requests for advice. Any Sales inquiries should include an email address or other means of communication.